Board of Directors of the Company in its meeting held on Friday, 14th August, 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7,86,690 ....
FUNDRAISE
▲ Positive Development
LOW RISK
📅 Filed on BSE: 14 Aug 2026, 01:05 PM IST · BSE ID: 8eff5c22-48e5-4078-a6a3-736b943a41f0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors agreed to convert warrants into shares, raising more capital by issuing new shares to promoters.
🤖 AI Summary
- Board approves allotment of 7,86,690 equity shares on warrant conversion.
- Issue price fixed at Rs. 89 per share, with Rs. 10 premium.
- Converts warrants for Rs. 5,25,11,557.5 to equity shares.
- Paid-up equity capital increases to Rs. 10,91,41,250.
- Allotment made to Promoters Category on a preferential basis.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares Allotted
7,86,690
Issue Price per Share
Rs. 89/-
Premium per Share
Rs. 10/-
Amount Received on Conversion
Rs. 5,25,11,557.5/-
Old Paid-up Equity Capital
Rs. 10,12,74,350/-
New Paid-up Equity Capital
Rs. 10,91,41,250/-
Old Number of Equity Shares
1,01,27,435
New Number of Equity Shares
1,09,14,125
Face Value per Share
Rs. 10/-
Outstanding Warrants
15,73,375
🏢 How This Affects the Company
The paid-up equity capital of the company has increased from Rs. 10,12,74,350 to Rs. 10,91,41,250 following the conversion of warrants into equity shares.
👥 What This Means For Shareholders
✅
Action Required
No action is required from existing shareholders regarding this allotment.
👤
Who Is Affected
Shareholders are affected by the increase in total equity shares outstanding.
🔍
Management Signal
Management is executing on its approved preferential allotment strategy to raise capital.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Further conversions of remaining outstanding warrants.
Disclosure of next quarter's financial results.
Updates on any further capital raising initiatives.
LOW RISK
Standard execution of prior approved warrant conversion process.
💡 Investor Takeaway
Godavari Drugs' Board approved allotting 7,86,690 equity shares on warrant conversion at Rs. 89 each, increasing paid-up capital to Rs. 10,91,41,250.
⚖️ Strengths & Concerns
✅ Positives
- Completion of warrant conversion increases paid-up equity capital to Rs. 10,91,41,250.
- Promoter category conversion confirms continued commitment and capital infusion.
⚠️ Concerns
- 15,73,375 warrants remain outstanding for future conversion.
- Significant portion of warrant issuance price (75%) was paid upon conversion.
❓ Frequently Asked Questions
How many equity shares did Godavari Drugs allot on warrant conversion?
Godavari Drugs allotted 7,86,690 equity shares upon conversion of warrants.
What is the issue price for the new equity shares?
The issue price for the new equity shares is Rs. 89/- each, including a premium of Rs. 10/-.
What is the total amount received on conversion of these warrants?
The company received Rs. 5,25,11,557.5/- on conversion of these warrants.
What is the new paid-up equity capital of Godavari Drugs after allotment?
The paid-up equity capital of Godavari Drugs has increased to Rs. 10,91,41,250/-.
Who are the allottees of these newly converted equity shares?
The equity shares were allotted to the 'Promoters Category' on a preferential basis.
Questions based on this BSE filing only. For information purposes.